Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects

Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme

Newcastle disease virus (NDV): brief history of its oncolytic strains

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire